help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, W. J.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, W. J.
Right arrow Articles by Clemmons, D. R.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 12 3982-3988
Copyright © 1997 by The Endocrine Society


From the Clinical Research Centers

Use of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein Measurements to Monitor Feeding of Premature Infants1

W. Jackson Smith2, Louis E. Underwood, Lynette Keyes and David R. Clemmons

Divisions of Endocrinology, Departments of Pediatrics and Medicine (W.J.S., L.E.U., D.R.C.), Design and Statistics Unit (L.K.), Frank Porter Child Development Center, University of North Carolina, Chapel Hill, North Carolina 27599

Address all correspondence and requests for reprints to: David R. Clemmons, M.D., CB #7170, University of North Carolina, Chapel Hill, North Carolina 27599.

To determine whether peptides of the insulin-like growth factor (IGF) system might be useful indicators of nutritional adequacy in premature infants, we studied 50 premature (25–34 weeks gestation) infants prospectively to define the relationship between nutrient intake and serum concentrations of IGF-I, IGF-binding protein-2 (IGFBP-2), and IGFBP-3. Each infant was monitored for at least 2 weeks. Nutrient intake was quantified from daily logs; weight was determined daily, and measurements of IGF-I, IGFBP-2, and IGFBP-3 in serum were made twice weekly.

Serum IGF-I correlated strongly with length of gestation, increasing 4.03 ± 0.95 ng/mL for each additional week of gestation (P < 0.0001) and 0.36 ± 0.07 ng/mL·day each day since birth (P < 0.0001). A higher intake of calories increased IGF-I by 0.07 ± 0.01 ng/mL for each calorie per kg ingested over the previous 3 days (P < 0.0001). IGF-I increased quadratically as protein intake increased. For each change of 1% in calories as protein squared, IGF-I increased 0.36 ± 0.11 ng/mL (P < 0.0001).

Serum IGFBP-3 concentrations also correlated with length of gestation, increasing 25.06 ± 11.83 µg/L·wk (P = 0.035) and 4.14 ± 1.33 µg/·day since birth (P = 0.003). Unlike IGF-I, variation in the amount of protein supplied did not change IGFBP-3. As calorie intake increased, IGFBP-3 increased by 0.54 ± 0.17 µg/L for each calorie per kg consumed over the previous 3 days (P = 0.0015).

In contrast to IGF-I and IGFBP-3, IGFBP-2 declined as the length of gestation increased (56.12 ± 16.92 ng/mL·week; P = 0.001) and with each additional day of life (7.57 ± 2.44 ng/mL·day; P = 0.003). Dietary protein, the predominant regulator of IGFBP-2, caused a decrease of 33.22 ± 9.00 ng/mL with each percent increase in dietary calories as protein (P < 0.0003). Calorie intake had less effect on IGFBP-2 than protein intake.

These results indicate that each of the three peptides studied is regulated in premature infants by nutritional intake, and that their regulatory patterns are qualitatively similar to those observed in older individuals. Measurements of these peptides in premature infants may be useful indicators of nutritional status and adequacy of nutrient intake.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. C. R. Prickett, B. Dixon, C. Frampton, T. G. Yandle, A. M. Richards, E. A. Espiner, and B. A. Darlow
Plasma Amino-Terminal Pro C-Type Natriuretic Peptide in the Neonate: Relation to Gestational Age and Postnatal Linear Growth
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 225 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Chellakooty, A. Juul, K. A. Boisen, I. N. Damgaard, C. M. Kai, I. M. Schmidt, J. H. Petersen, N. E. Skakkebaek, and K. M. Main
A Prospective Study of Serum Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in 942 Healthy Infants: Associations with Birth Weight, Gender, Growth Velocity, and Breastfeeding
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 820 - 826.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Balogh, A. Treszl, A. Vannay, and B. Vasarhelyi
A Prevalent Functional Polymorphism of Insulin-Like Growth Factor System Is Not Associated With Perinatal Complications in Preterm Infants
Pediatrics, February 1, 2006; 117(2): 591 - 592.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. Roelfsema, A. J. Gunn, B. H. Breier, J. S. Quaedackers, and L. Bennet
The Effect of Mild Hypothermia on Insulin-like Growth Factors After Severe Asphyxia in the Preterm Fetal Sheep
Reproductive Sciences, May 1, 2005; 12(4): 232 - 237.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
H.-C. Lo, L.-Y. Tsao, W.-Y. Hsu, C.-Y. Chi, and F.-A. Tsai
Changes in Serum Insulin-Like Growth Factors, Not Leptin, Are Associated With Postnatal Weight Gain in Preterm Neonates
JPEN J Parenter Enteral Nutr, March 1, 2005; 29(2): 87 - 92.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Hellstrom, E. Engstrom, A.-L. Hard, K. Albertsson-Wikland, B. Carlsson, A. Niklasson, C. Lofqvist, E. Svensson, S. Holm, U. Ewald, et al.
Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated With Retinopathy of Prematurity and Other Complications of Premature Birth
Pediatrics, November 1, 2003; 112(5): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kajantie, L. Dunkel, E.-M. Rutanen, M. Seppala, R. Koistinen, A. Sarnesto, and S. Andersson
IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2171 - 2179.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Hellstrom, C. Perruzzi, M. Ju, E. Engström, A.-L. Hård, J.-L. Liu, K. Albertsson-Wikland, B. Carlsson, A. Niklasson, L. Sjödell, et al.
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity
PNAS, May 1, 2001; (2001) 101113998.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Hellstrom, C. Perruzzi, M. Ju, E. Engstrom, A.-L. Hard, J.-L. Liu, K. Albertsson-Wikland, B. Carlsson, A. Niklasson, L. Sjodell, et al.
Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity
PNAS, May 8, 2001; 98(10): 5804 - 5808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society